| Identification | Back Directory | [Name]
5-(furan-2-yl)-N-(4-(pyridin-4-yl)butyl)isoxazole-3-carboxaMide | [CAS]
1268674-16-3 | [Synonyms]
5-(furan-2-yl)-N-(4-(pyridin-4-yl)butyl)isoxazole-3-carboxaMide
3-Isoxazolecarboxamide, 5-(2-furanyl)-N-[4-(4-pyridinyl)butyl]- | [Molecular Formula]
C17H17N3O3 | [MOL File]
1268674-16-3.mol | [Molecular Weight]
311.34 |
| Chemical Properties | Back Directory | [Boiling point ]
567.6±50.0 °C(Predicted) | [density ]
1.209±0.06 g/cm3(Predicted) | [storage temp. ]
2-8°C | [solubility ]
DMSO: 50mg/mL | [form ]
Solid | [pka]
13.73±0.46(Predicted) | [color ]
Light yellow to yellow |
| Hazard Information | Back Directory | [Uses]
HDAC-IN-55(8j) is a small molecular compound that can increase the expression of E-cadherin and inhibit the proliferation of cancer cells[1]. | [References]
[1] Sydney L Stoops, et al. Identification and optimization of small molecules that restore E-cadherin expression and reduce invasion in colorectal carcinoma cells. ACS Chem Biol. 2011 May 20;6(5):452-65. DOI:10.1021/cb100305h |
|
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
|